Leadership

OrbiMed's team includes over 80 experienced professionals with expertise in the life sciences industry, medicine, finance, and law.

This complementary mix of deep operating skills, investment experience and scientific acumen provides the firm with a solid foundation from which to seek successful investments.

OrbiMed's structure combines the focus of specialists dedicated to specific market sectors with the synergies of a broad investment team spanning both public equity and private markets worldwide. We foster significant collaboration between our public and private equity analysts through shared weekly portfolio meetings, joint research projects and frequent informal interaction.